Product Images Vagisten-v 7 Day

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Vagisten-v 7 Day NDC 69729-612 by Opmx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

0-UC_VAGISTEN-V CREMA 2pct_back - 0 UC VAGISTEN V CREMA 2pct back

0-UC_VAGISTEN-V  CREMA 2pct_back - 0 UC VAGISTEN V  CREMA 2pct back

This is a drug fact sheet for a medication containing 2% miconazole nitrate in a cream form. It is to be used for the treatment of vaginal yeast infections, external itching and irritation, and is applied via an applicator. The user is advised to ask a doctor before use if she has never had a yeast infection diagnosed, if experiencing new symptoms, if experiencing serious symptoms or if taking prescription blood thinning medication. It also warns not to use if there are punctures on the tube opening, to avoid using other vaginal products, and store at 20°-25°C.*

0-UC_VAGISTEN-V CREMA 2pct_front - 0 UC VAGISTEN V CREMA 2pct front

0-UC_VAGISTEN-V  CREMA 2pct_front - 0 UC VAGISTEN V  CREMA 2pct front

This is a description of Vagisten-V, an antifungal vaginal cream that contains 2% of miconazole nitrate in a dose of 100mg per applicator. It is intended to cure vaginal yeast infections and relieve associated external itching and irritation. The net weight of the cream is noted, as is the fact that it is an effective treatment against vaginal infections. It is distributed exclusively by Innovarix Farmaceutique and the company is located in San Diego, California.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.